Rapporto sull’analisi delle dimensioni del mercato dei dispositivi per artroscopia e delle quote | Previsioni 2031

  • Report Code : TIPRE00020213
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 169
Buy Now

Si prevede che il mercato dei dispositivi per artroscopia raggiungerà i 9.853,88 milioni di dollari entro il 2028 rispetto ai 5.725,24 milioni di dollari del 2021; si prevede che registrerà un CAGR dell'8,1% dal 2021 al 2028.

L'artroscopia è una procedura per la diagnosi e il trattamento dei problemi articolari. Un chirurgo inserisce un tubo stretto collegato a una videocamera a fibre ottiche chiamata artroscopio attraverso una piccola incisione delle dimensioni di un'asola. Un artroscopio è un dispositivo medico che consente ai medici di vedere all'interno delle articolazioni del corpo come ginocchio, anca, colonna vertebrale, spalla e gomito per ispezionare, diagnosticare ed eseguire procedure terapeutiche. I dispositivi per artroscopia possono esaminare malattie come l'artrosi, l'artrite reumatoide, le tendiniti e i tumori ossei delle articolazioni.  

Il rapporto offre approfondimenti e analisi approfondite del mercato dei dispositivi per artroscopia sottolineando vari parametri come le tendenze del mercato, i progressi tecnologici e le dinamiche di mercato. Fornisce inoltre l’analisi del panorama competitivo dei principali attori del mercato in tutto il mondo. Inoltre, include l’impatto della pandemia COVID-19 sul mercato in tutte le regioni. La pandemia di COVID-19 ha creato sia una crisi sanitaria pubblica che una crisi economica in tutto il mondo. Prima della pandemia, il mercato globale dei dispositivi per artroscopia era in costante crescita grazie allo screening, ai trattamenti di conforto e ai trattamenti regolari. La prima ondata di COVID-19 ha interrotto le consultazioni, i follow-up e gli screening dei casi oncologici. La situazione incontrollata che si è creata nel settore sanitario a livello mondiale ha portato alla riduzione del numero di consultazioni e al minor numero di casi diagnosticati di osteoartrosi e artrite reumatoide. Diverse aziende hanno subito gravi perdite nell’ultimo trimestre del 2019; la pandemia ha influenzato negativamente anche il primo e il secondo trimestre del 2020. L’impatto della pandemia di COVID-19 sul mercato globale è stato quindi immediato e drastico. Le imprese di tutto il mondo sono state ostacolate a causa dell’interruzione della catena di approvvigionamento e dell’aumento della domanda di prodotti e servizi sanitari. Per ridurre l’infezione da COVID-19 negli ospedali e nelle cliniche, gli operatori sanitari e i pazienti hanno adottato e preferito il trattamento a distanza. In queste circostanze imprevedibili, la pratica ortopedica non poteva rimanere inalterata. Molti trattamenti chirurgici e consultazioni non urgenti sono stati annullati o rinviati. La chirurgia elettiva è stata sospesa in molte istituzioni e il volume complessivo dei casi ortopedici è diminuito drasticamente per limitare la diffusione del virus e riservare e riallocare le risorse nel personale sanitario (infermieri, anestesisti), nelle attrezzature mediche (dispositivi di protezione individuale, ventilatori), e letti. La strategia dello "stare a casa" nel mondo ha comportato una significativa riduzione degli interventi di artroplastica e artroscopia, nonché una diminuzione dell'incidenza dei casi di osteoartrosi durante il periodo COVID-19.

Approfondimenti strategici

Poiché l'infrastruttura sanitaria è stata interrotta a causa dell'epidemia di COVID-19 e l'attenzione è stata spostata sul trattamento del COVID-19, la diagnosi di varie malattie è stata trascurata. Inoltre, anche l’individuazione e il trattamento delle malattie muscolo-scheletriche sono stati ostacolati dalla pandemia di COVID-19. Ciò ha notevolmente frenato la crescita del mercato dei dispositivi per artroscopia in tutto il mondo.  

Regioni redditizie per il mercato dei dispositivi per artroscopia

Approfondimenti di mercato
Crescente prevalenza di disturbi muscoloscheletrici per guidare il mercato

I disturbi muscoloscheletrici (DMS) sono le condizioni sanitarie più comuni in tutto il mondo. Secondo i dati pubblicati dall’Organizzazione Mondiale della Sanità (OMS), nel febbraio 2021, circa 1,71 miliardi di persone nel mondo soffrivano di problemi muscolo-scheletrici. La lombalgia è una condizione muscoloscheletrica diffusa, che colpisce 568 milioni di persone in tutto il mondo. La lombalgia è la principale causa di disabilità in 160 paesi. I disturbi muscoloscheletrici compromettono gravemente la mobilità e la destrezza, con conseguente pensionamento anticipato dal lavoro, diminuzione del benessere e della capacità di socializzare. Il numero di persone disabili a causa di patologie muscolo-scheletriche è in aumento e si prevede che questa tendenza continui nei prossimi decenni.

Inoltre, secondo l'OMS, i paesi ad alto reddito sono i più colpiti in termini di popolazione (441 milioni), seguiti dai paesi della regione del Pacifico occidentale dell’OMS con 427 milioni, mentre il Sud-est asiatico ne ha 369 milioni. Le malattie muscoloscheletriche sono anche la principale causa di anni vissuti con disabilità (YLD) in tutto il mondo, rappresentando circa 149 milioni di YLD, ovvero il 17% di tutti gli YLD. Le fratture, che colpiscono 436 milioni di persone in tutto il mondo, l'osteoartrosi (343 milioni), altre lesioni (305 milioni), i dolori al collo (222 milioni), le amputazioni (175 milioni) e l'artrite reumatoide (14 milioni) contribuiscono tutti all'onere complessivo delle malattie muscoloscheletriche.

L'artroscopia chirurgica è un'opzione terapeutica consolidata per i soggetti con dolore articolare cronico e disfunzione. Rispetto alle procedure articolari aperte, l'artroscopia è meno invasiva e determina risultati complessivi migliori per il paziente in termini di trattamento dei sintomi, degenza ospedaliera, recupero strutturale ed esiti a lungo termine. Pertanto, si prevede che la crescente prevalenza di disturbi muscoloscheletrici, osteoartrite e artrite reumatoide guiderà il mercato durante il periodo di previsione.

Approfondimenti basati sul prodotto

In base al prodotto, i dispositivi per artroscopia Il mercato è segmentato in artroscopi, impianti artroscopici, sistemi di gestione dei fluidi, sistemi a radiofrequenza, sistemi di visualizzazione, sistemi di rasoio elettrico e altre apparecchiature artroscopiche. Nel 2021, il segmento degli artroscopi deteneva la quota maggiore del mercato e si prevede che registrerà il CAGR più rapido del 9,1% durante il periodo di previsione.  

Mercato dei dispositivi per artroscopia, per prodotto - 2020 e 2028

Approfondimenti basati sull'applicazione

In base all'applicazione, il mercato dei dispositivi per artroscopia è segmentato in artroscopia del ginocchio, artroscopia dell'anca, artroscopia della colonna vertebrale, artroscopia del piede e artroscopia della caviglia, artroscopia della spalla e del gomito e altri. Nel 2021, il segmento dell'artroscopia dell'anca deteneva la quota maggiore del mercato e si prevede che registrerà il CAGR più elevato dell'8,9% nel periodo 2021-2028.

Gli operatori del mercato dei dispositivi per artroscopia adottano strategie organiche come il lancio del prodotto e espansione per espandere la propria presenza e il portafoglio di prodotti in tutto il mondo e soddisfare le crescenti richieste.

Per area geografica

In base all'area geografica, il mercato dei dispositivi per artroscopia è segmentato in Nord America (Stati Uniti, Canada, e Messico), Europa (Regno Unito, Germania, Francia, Italia, Spagna e resto d'Europa), Asia Pacifico (Cina, Giappone, India, Australia, Corea del Sud e resto dell'Asia Pacifico), Medio Oriente e ; Africa (Emirati Arabi Uniti, Arabia Saudita, Sud Africa e resto del Medio Oriente e dell'Africa) e Sud e Africa. America Centrale (Brasile, Argentina e il resto dell'America centrale e meridionale).

Profili aziendali

  • Arthrex, Inc.
  • CONMED Corporation
  • Johnson and Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • Medtronic
  • Richard Wolf GmbH.
  • Smith & Nipote
  • Stryker Corporation
  • Zimmer Biomet
  • NuVasive, Inc.  
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is an arthroscopy device?

Arthroscopy is a procedure for diagnosing and treating joint problems. A surgeon inserts a narrow tube attached to a fiber-optic video camera through a small incision about the size of a buttonhole which is called an arthroscope. An arthroscope is a medical device that allows doctors to see within bodily joints such as the knee, hip, spine, shoulder, and elbow to inspect, diagnose, and perform therapeutic procedures. Arthroscopy devices can examine for illnesses like osteoarthritis, rheumatoid arthritis, tendinitis, and bone tumors in the joints.

What are the driving factors for the arthroscopy devices market across the globe?

Key factors that are driving the growth of this market are the growing prevalence of musculoskeletal disorders osteoarthritis and rheumatoid arthritis, rising number of sport injuries requiring arthroscopy procedure to prevent complete joint and rising elderly population. Additionally, the increasing prevalence of obesity and rising number of product launches and approvals are likely to emerge as a significant future trend in the market during the forecast period.

What is the market CAGR value of the arthroscopy devices market during the forecast period?

The CAGR value of the arthroscopy devices market during the forecasted period of 2021–2028 is 8.1%.

Which product led the arthroscopy devices market?

In 2021, the arthroscopes segment accounted for the largest share of the market; it is further expected to continue its dominance over the forecast period. The arthroscopes are primarily used in the minimally invasive strategy. It aids patients' recovery and reduces scarring. Moreover, the decrease in the life span of arthroscopes due to the sterilization process used to prevent contamination and the launch of single-use arthroscopes. Thus, due to above factors, the arthroscopes segment is expected to dominate the arthroscopy devices market by product segment. Moreover, arthroscopes are expected to register the highest CAGR in arthroscopy devices market during 2021-2028.

Which application held the largest share in the arthroscopy devices market?

In 2021, the hip arthroscopy held the largest share of the market, by application. The similar application segment of the arthroscopy devices market is expected to witness growth in its demand at the fastest CAGR from 2021 to 2028.

Who are the key players in the arthroscopy devices market?

The arthroscopy devices market majorly consists of players such as Arthrex, Inc.; CONMED Corporation; Johnson and Johnson Services, Inc.; KARL STORZ SE & Co. KG; Medtronic; Richard Wolf GmbH.; Smith & Nephew; Stryker Corporation; Zimmer Biomet; and NuVasive, Inc amongst others.

Which are the top companies that hold the market share in arthroscopy devices market?

Johnson and Johnson Services, Inc and CONMED Corporation are the top two companies that hold huge market shares in the arthroscopy devices market.

Which region is expected to witness significant demand for the arthroscopy devices market in the coming years?

The North America region secures the major share of the global arthroscopy devices market. Rapid increase in the number of arthroscopies in the region, advancements in arthroscopy products and the highly active research ecosystem for arthroscopic applications is projected to accelerate the growth of the market. Moreover, increasing prevalence of chronic diseases and orthopedic ailments, especially among the aging population in this region of arthroscopy devices is propelling the market's expansion in this region.

What is the COVID 19 impact on the arthroscopy devices market in the coming years?

Due to an increasing number of infected patients worldwide, several research institutes and leading organizations put an effort to develop efficient methods of COVID 19 treatment and ways to combat pandemic. Many companies manufacturing arthroscopy devices focused on responding emergencies by various strategies such as manufacturing PPEs to healthcare workers, distribution of pharmaceutical drugs and various other activities. For instance, in September 2020, Arthrex, a global leader in minimally invasive orthopedic technology, announced it is using its innovative production capabilities to manufacture and donate more than 6,000 protective face shields to school systems across the region.
According to World Health Organization (WHO). As the epidemic has become a global pandemic, many health authorities focused pandemic-related care and avoided human contact in reaction to growing transmission and strain on health-care resources by postponing elective surgeries, suspending outpatient clinics, and triaging employees involved in urgent care. For instance, as per the British Journal of Surgery published in May 2020 stated that orthopedic procedures would be affected most, with 6.3 million operations cancelled worldwide. Recent COVID-19 guidelines for pediatric orthopedic surgeons suggested focus on urgent care and triaging cases to postpone elective surgeries and clinic appointments, with transition to virtual-based care when appropriate.
Thus, the pandemic had a negative impact on the arthroscopy market in the region.

The List of Companies - Arthroscopy Devices Market

  1. Arthrex, Inc.          
  2. CONMED Corporation       
  3. Johnson and Johnson Services, Inc.             
  4. KARL STORZ SE & Co. KG                  
  5. Medtronic              
  6. Richard Wolf GmbH.          
  7. Smith & Nephew                
  8. Stryker Corporation           
  9. Zimmer Biomet    
  10. NuVasive, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports